FI953505A0 - Paikalliset ketokonatsolikoostumukset - Google Patents

Paikalliset ketokonatsolikoostumukset

Info

Publication number
FI953505A0
FI953505A0 FI953505A FI953505A FI953505A0 FI 953505 A0 FI953505 A0 FI 953505A0 FI 953505 A FI953505 A FI 953505A FI 953505 A FI953505 A FI 953505A FI 953505 A0 FI953505 A0 FI 953505A0
Authority
FI
Finland
Prior art keywords
pct
local
ketoconazole
sec
date
Prior art date
Application number
FI953505A
Other languages
English (en)
Swedish (sv)
Other versions
FI953505A (fi
FI114009B (fi
Inventor
Marc Karel Jozef Francois
Alfons Jeanne Wouters
Gerard Frans Maria Cauwenbergh
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI953505A publication Critical patent/FI953505A/fi
Publication of FI953505A0 publication Critical patent/FI953505A0/fi
Application granted granted Critical
Publication of FI114009B publication Critical patent/FI114009B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FI953505A 1993-01-21 1995-07-20 Menetelmä paikallisten ketokonatsolikoostumusten valmistamiseksi FI114009B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93200145 1993-01-21
EP93200145 1993-01-21
EP9400092 1994-01-12
PCT/EP1994/000092 WO1994016710A1 (en) 1993-01-21 1994-01-12 Topical ketoconazole compositions

Publications (3)

Publication Number Publication Date
FI953505A FI953505A (fi) 1995-07-20
FI953505A0 true FI953505A0 (fi) 1995-07-20
FI114009B FI114009B (fi) 2004-07-30

Family

ID=8213579

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953505A FI114009B (fi) 1993-01-21 1995-07-20 Menetelmä paikallisten ketokonatsolikoostumusten valmistamiseksi

Country Status (19)

Country Link
US (1) US5654293A (fi)
EP (1) EP0680328B1 (fi)
JP (1) JP3918119B2 (fi)
KR (1) KR100300525B1 (fi)
CN (1) CN1096860C (fi)
AT (1) ATE146965T1 (fi)
AU (1) AU683865B2 (fi)
CA (1) CA2153681C (fi)
CY (1) CY2106B1 (fi)
DE (1) DE69401336T2 (fi)
DK (1) DK0680328T3 (fi)
ES (1) ES2098921T3 (fi)
FI (1) FI114009B (fi)
GR (1) GR3022212T3 (fi)
HK (1) HK1005999A1 (fi)
HU (1) HU221319B1 (fi)
NZ (1) NZ259866A (fi)
RU (1) RU2126256C1 (fi)
WO (1) WO1994016710A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721212B1 (fr) * 1994-06-17 1996-09-13 Pf Medicament Composition et procédé d'obtention d'une émulsion de désonide.
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
FR2747568B1 (fr) * 1996-04-17 1999-09-17 Oreal Utilisation d'au moins un inhibiteur de lipoxygenase et d'au moins un inhibiteur de cyclo-oxygenase pour modifier la pousse des poils et/ou des cheveux
EP0872229A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Compositions containing an antifungal and a phospholipid
JP2001520188A (ja) * 1997-10-22 2001-10-30 ポニカウ，ジェンス 粘膜組織の炎症を治療および予防するための方法ならびに物質
US6238683B1 (en) 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
GB9915625D0 (en) 1999-07-02 1999-09-01 Cortendo Ab Method
SE9902675D0 (sv) * 1999-07-12 1999-07-12 Astra Ab Pharmaceutical formulations, doses & regimens
GB2365770B (en) * 2000-08-18 2002-07-31 Diomed Dev Ltd Antifungal ketoconazole composition for topical use
CA2528776A1 (en) * 2002-10-24 2004-05-06 G & R Pharmaceuticals, Llc Antifungal formulations
DE102004014617A1 (de) * 2004-03-22 2005-10-13 Beiersdorf Ag Kosmetisches Produkt, umfassend eine thixotropiearme Öl-in-Wasser-Emulsion und einen transparenten Behälter
JP5007427B2 (ja) * 2004-05-13 2012-08-22 アルザ コーポレイション 副甲状腺ホルモン剤の経皮送達のための装置および方法
DE102004032837A1 (de) * 2004-07-02 2006-02-09 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
CN100418530C (zh) * 2005-04-06 2008-09-17 河南省眼科研究所 一种酮康唑滴眼液及其制造方法
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
JP6336902B2 (ja) 2011-06-22 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー．リミテッド コンジュゲートベースの抗真菌性および抗菌性プロドラッグ
US9029342B2 (en) 2012-09-17 2015-05-12 Board Of Regents Of The University Of Texas System Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
KR101814895B1 (ko) 2013-06-04 2018-01-04 바이옴 바이오사이언스 피브이티. 엘티디. 코팅된 입자 및 이를 포함하는 조성물
BE1022727B1 (nl) * 2015-04-20 2016-08-24 Stasisport Pharma Nv Fusidinezuur crème en methode voor het maken hiervan
CN107260656B (zh) * 2016-04-08 2021-02-09 湖北人福成田药业有限公司 地奈德乳膏及其制备方法
WO2018144841A1 (en) * 2017-02-03 2018-08-09 Board Of Regents, The University Of Texas System Topical voriconazole for the treatment of pain
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
WO1992018133A1 (en) * 1991-04-11 1992-10-29 Drore Eisen Method of treatment using steroid mouthwash

Also Published As

Publication number Publication date
DE69401336T2 (de) 1997-04-24
HU9501959D0 (en) 1995-09-28
EP0680328A1 (en) 1995-11-08
AU5883394A (en) 1994-08-15
ES2098921T3 (es) 1997-05-01
EP0680328B1 (en) 1997-01-02
CN1116824A (zh) 1996-02-14
NZ259866A (en) 1999-07-29
DK0680328T3 (da) 1997-01-20
US5654293A (en) 1997-08-05
KR100300525B1 (ko) 2001-10-22
JPH08505861A (ja) 1996-06-25
FI953505A (fi) 1995-07-20
AU683865B2 (en) 1997-11-27
CA2153681A1 (en) 1994-08-04
HK1005999A1 (en) 1999-02-05
HUT73233A (en) 1996-07-29
JP3918119B2 (ja) 2007-05-23
CA2153681C (en) 2004-05-25
CY2106B1 (en) 2002-04-26
CN1096860C (zh) 2002-12-25
FI114009B (fi) 2004-07-30
RU2126256C1 (ru) 1999-02-20
HU221319B1 (en) 2002-09-28
WO1994016710A1 (en) 1994-08-04
DE69401336D1 (de) 1997-02-13
ATE146965T1 (de) 1997-01-15
GR3022212T3 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
FI953505A0 (fi) Paikalliset ketokonatsolikoostumukset
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
ES2137549T3 (es) Derivados antifungicos de sordaridina.
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE137959T1 (de) Liposomale piroxycam formulierung
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
DE69703796D1 (de) N-bis- oder n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amin-derivate und herstellung und anwendung derselben
ES2169126T3 (es) Composicion que contiene retinal.
DE69228814D1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
NO951657D0 (no) Nöytral selvglansemulsjon for pleie av gulv (III)
BG102213A (en) Endoparasiticidic composition based on didepsipeptides, new didepsipeptides and method for their preparation
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
ES2135710T3 (es) Procedimiento para preparar espirolaxina y eter metilico de espirolaxina.
ATE175668T1 (de) Verfahren zur herstellung von 8-g(a),12-oxido- 13,14,15,16-tetranorlabdan
ATE293605T1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren

Legal Events

Date Code Title Description
MA Patent expired